In our study, ChIP and luciferase reporter gene assays indicated PAX5 transcriptionally promotes the expression of HK2 and PKM2, thus promoting glycolysis and proliferation of GBM cells, playing a role as a pro-oncogenic factor. The gene discussed is HK2; the disease is glioblastoma.